Skip to main content
WeightCited

Berberine 用于 多囊卵巢综合征相关体重管理

C 证据 来自小型研究的证据有限，但存在一些积极信号。

Systematic reviews suggest berberine may be comparable to metformin for insulin resistance in PCOS. Small RCTs show improvements in BMI, testosterone, and metabolic markers. Berberine is commonly combined with inositol in clinical protocols.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dpcos\u002Dweight'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
结论

            
            
Systematic reviews suggest berberine may be comparable to metformin for insulin resistance in PCOS. Small RCTs show improvements in BMI, testosterone, and metabolic markers. Berberine is commonly combined with inositol in clinical protocols.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in …
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: PCOS insulin resistance via gut microbiota
                
                
                效果: None
                
                
                None
                
            

            
            
研究人群: Women with PCOS and insulin resistance

            
        

        
        

            

                
                    Review
                
                
                
                
            

            
                Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: gut microbiota composition
                
                
                效果: None
                
                
                None
                
            

            
            
研究人群: None

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
6

        
研究数量

    

    

        
400

        
受试者

    

    

        
            
            ↑
            
        
        
Positive

    

    

        C

        
等级

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Frontiers in nutrition
                        2025
                        
                    

                

                
                

                    

                        
                            Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Clinical and experimental …
                        2023
                        
                        2 次引用
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
常用剂量

                

                    
                    

                        
general:

                        
500 mg 2-3x/day with meals

                    

                    
                    

                        
starting:

                        
500 mg/day and titrate

                    

                    
                    

                        
metabolicsupport:

                        
1,000-1,500 mg/day

                    

                    
                

                
                

                    上限： 1,500 mg/day; GI side effects limit intake; potential drug interactions
                

                
            

            

            
            

                
研究中使用的剂量

                

                    

                        
                            

                                剂量
                                持续时间
                                效果
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Mixed
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                最佳服用时间： With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
已报告的副作用

                    
    
                        
                        
  • 
                            ⚠
                            Diarrhea
                        
    • 
                        
                        
  • 
                            ⚠
                            Constipation
                        
    • 
                        
                        
  • 
                            ⚠
                            Flatulence
                        
    • 
                        
                        
  • 
                            ⚠
                            Abdominal pain
                        
    • 
                        
                        
  • 
                            ⚠
                            Potential hypoglycemia (when combined with diabetes medications)
                        
    • 
                        
                    

                

                

                
                

                    
已知相互作用

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may potentiate — hypoglycemia risk)
                        
    • 
                        
                        
  • 
                            ●
                            CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
                        
    • 
                        
                        
  • 
                            ●
                            CYP2D6 substrates
                        
    • 
                        
                        
  • 
                            ●
                            Cyclosporine
                        
    • 
                        
                        
  • 
                            ●
                            Metformin (additive effects)
                        
    • 
                        
                    

                

                

                
                

                    

                        可耐受最高摄入量： 1,500 mg/day; GI side effects limit intake; potential drug interactions
                    

                

                
            

            

                在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Berberine help with 多囊卵巢综合征相关体重管理?
            
        
        

            Based on 6 studies with 400 participants, there is limited but promising evidence that Berberine may support 多囊卵巢综合征相关体重管理 management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Berberine should I take for 多囊卵巢综合征相关体重管理?
            
        
        

            Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Berberine?
            
        
        

            Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Berberine and 多囊卵巢综合征相关体重管理?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                

                    
其他成分用于 多囊卵巢综合征相关体重管理

                    

                        
                        
                            Vitamin D
                            B

                        
                        
                        
                            Chromium
                            C

                        
                        
                    

                

                

                
                

                    
Berberine 用于其他健康状况

                    

                        
                        
                            胰岛素抵抗
                            A

                        
                        
                        
                            代谢综合征
                            A

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Lin Yin et al..
      Front Nutr.
      2025.
      The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome.
      doi:10.3389/fnut.2025.1700612
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Ting-Wei Zhu et al..
      Clin Exp Pharmacol Physiol.
      2023.
      Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome.
      doi:10.1111/1440-1681.13814
      PubMed
    
    3. 
    
  















    

        FDA 免责声明:
        这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。